Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12020-021-02671-8 http://scihub22266oqcxt.onion/10.1007/s12020-021-02671-8 33738708!7972333!33738708     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Endocrine 2021 ; 72 (1): 1-11 Nephropedia Template TP {{tp|p=33738708|t=2021. Hypovitaminosis D and the endocrine phenotype of COVID-19 |pdf=|usr=}}{{33738708}} gab.com Text Hypovitaminosis D and the endocrine phenotype of COVID-19 JO: Endocrine http://www.kidney.de/pget.php?&tw=1&pmid=33738708 #FOAvip BACKGROUND: Vitamin D and its deficiency have recently been suspected to be involved in increased susceptibility and negative outcomes of COVID-19. This assumption was based on the well known immunomodulatory actions of vitamin D and on the consistent finding of low levels of 25 hydroxyvitamin D (25OHD) in hospitalized patients with COVID-19. Moreover, several studies reported a correlation between 25OHD levels and different clinical outcomes of the disease. AIM: Aim of the current review was to approach the topic of vitamin D and COVID-19 from a different perspective summarizing the data which led to the evidence of the existence of an endocrine phenotype of COVID-19. CONCLUSIONS: This review analyzed in the light of the current knowledge the possibility that several endocrine manifestations of COVID-19 could be holistically interpreted in the context of an inadequate vitamin D status. Twit Text FOAVip Hypovitaminosis D and the endocrine phenotype of COVID-19 ????Endocrine http://www.kidney.de/pget.php?&tw=1&pmid=33738708 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33738708 #FOAvip English Wikipedia <ref>{{Cite pmid|33738708}}</ref> Hypovitaminosis D and the endocrine phenotype of COVID-19 #MMPMID33738708 Giustina A Endocrine 2021[Apr]; 72 (1): 1-11 PMID33738708show ga BACKGROUND: Vitamin D and its deficiency have recently been suspected to be involved in increased susceptibility and negative outcomes of COVID-19. This assumption was based on the well known immunomodulatory actions of vitamin D and on the consistent finding of low levels of 25 hydroxyvitamin D (25OHD) in hospitalized patients with COVID-19. Moreover, several studies reported a correlation between 25OHD levels and different clinical outcomes of the disease. AIM: Aim of the current review was to approach the topic of vitamin D and COVID-19 from a different perspective summarizing the data which led to the evidence of the existence of an endocrine phenotype of COVID-19. CONCLUSIONS: This review analyzed in the light of the current knowledge the possibility that several endocrine manifestations of COVID-19 could be holistically interpreted in the context of an inadequate vitamin D status. |*COVID-19[MESH] |*Vitamin D Deficiency/complications[MESH] |Humans[MESH] |Phenotype[MESH] |SARS-CoV-2[MESH] |Vitamin D[MESH]Hypovitaminosis D and the endocrine phenotype of COVID-19 (epmc).pdf DeepDyve Pubget Overpricing